Korro to Present at the TD Cowen 44th Annual Health Care Conference
February 27 2024 - 8:00AM
Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that Chief
Executive Officer and President, Ram Aiyar, Ph.D., will present at
the TD Cowen 44th Annual Health Care Conference in Boston,
Massachusetts, on Monday, March 4, 2024, at 2:10 p.m. ET. Chief
Financial Officer, Vineet Agarwal, and Chief Scientific Officer,
Steve Colletti, will also be participating at the conference.
A live webcast of the presentation can be
accessed on the "Events & Presentations" page in the Investor
section of Korro’s website at www.korrobio.com. Following the
presentation, a replay of the event will be available for 30
days.
About KorroKorro is a
biopharmaceutical company focused on developing a new class of
genetic medicines for both rare and highly prevalent diseases using
its proprietary RNA editing platform. Korro is generating a
portfolio of differentiated programs that are designed to harness
the body’s natural RNA editing process to effect a precise yet
transient single base edit. By editing RNA instead of DNA, Korro is
expanding the reach of genetic medicines by delivering additional
precision and tunability, which has the potential for increased
specificity and improved long-term tolerability. Using an
oligonucleotide-based approach, Korro expects to bring its
medicines to patients by leveraging its proprietary platform with
precedented delivery modalities, manufacturing know-how, and
established regulatory pathways of approved oligonucleotide drugs.
Korro is based in Cambridge, Mass. For more information, visit
korrobio.com.
Investor Contact:IR@korrobio.com
Media Contact:Glenn Silver FINN
Partners Glenn.silver@finnpartners.com
Korro Bio (NASDAQ:KRRO)
Historical Stock Chart
From Sep 2024 to Oct 2024
Korro Bio (NASDAQ:KRRO)
Historical Stock Chart
From Oct 2023 to Oct 2024